Results 181 to 190 of about 584,093 (236)

Insulinoma Mimic: Tramadol-induced Hypoglycemia. [PDF]

open access: yesJCEM Case Rep
O'Hara S   +5 more
europepmc   +1 more source

Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes. [PDF]

open access: yesDiabetes Care
Triplitt C   +8 more
europepmc   +1 more source

Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review. [PDF]

open access: yesNeth Heart J
van Maren SJF   +5 more
europepmc   +1 more source

Effect of oral semaglutide on cardiometabolic risk factors in overweight and obese individuals with or without diabetes: a systematic review and meta-analysis. [PDF]

open access: yesBMC Pharmacol Toxicol
Seighali N   +12 more
europepmc   +1 more source

Pharmaceutical agents targeting K<sub>ATP</sub> channel modulate sweet taste sensitivity in mice. [PDF]

open access: yesJ Physiol Sci
Sawai C   +6 more
europepmc   +1 more source

Characterization and Significance of Sulfonylurea Receptors

Diabetes Care, 1990
This study describes and characterizes a putative sulfonylurea receptor. The radioligand used was [3H]glipizide (9 Ci/mmol). The β-cell plasma membranes were derived from a transplantable rat insulinoma generated by subcutaneous injection of RINm5F cells and purified by ultracentrifugation on a 15–55% sucrose gradient. Specific binding of [3H]glipizide
Harold E Lebovitz   +2 more
exaly   +3 more sources

A New Mesangial Triumvirate: Sulfonylureas, Their Receptors and Endosulfines

open access: yesNephron Experimental Nephrology, 2002
Although sulfonylureas have long been therapeutically utilized for their hypoglycemic properties in type 2 diabetic patients, there is a paucity of clinical or experimental data that suggests that this pharmacotherapeutic class confers a benefit on the course of diabetic renal disease.
Jerry, Yee, Balàzs, Szamosfalvi
core   +4 more sources

Home - About - Disclaimer - Privacy